C Rivas
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Retinoids in leukemia and cellular processes 2
- Protein Degradation and Inhibitors 1
-
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 1
- Co-authors
- Josep‐María Ribera (4 shared papers)Albert Oriol (3 shared papers)Eloy del Potro (2 shared papers)Teresa Bernal (2 shared papers)Salut Brunet (2 shared papers)Jesús María Hernández‐Rivas (2 shared papers)Pilar Bastida (2 shared papers)Evarist Feliú (2 shared papers)
In The Last Decade
C Rivas
10 papers receiving 438 citations
Peers
Comparison fields: 5 of 37
- Hematology 279
- Public Health, Environmental and Occupational Health 291
- Oncology 111
- Genetics 41
- Pediatrics, Perinatology and Child Health 52
Countries citing papers authored by C Rivas
This map shows the geographic impact of C Rivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Rivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Rivas more than expected).
Fields of papers citing papers by C Rivas
This network shows the impact of papers produced by C Rivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Rivas. The network helps show where C Rivas may publish in the future.
Co-authors
The 25 scholars most cited alongside C Rivas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 210 | |
| 2 | 2009 | 134 | |
| 3 | Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA. | 2001 | 49 |
| 4 | Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL. | 2001 | 26 |
| 5 | 2001 | 17 | |
| 6 | Nuclear bodies in Hodgkin's disease. | 1974 | 4 |
| 7 | 2024 | 3 | |
| 8 | 2005 | 1 | |
| 9 | 2015 | 1 | |
| 10 | [Castleman's disease. A multifactorial study]. | 1992 | 1 |
About C Rivas
C Rivas is a scholar working on Molecular Biology, Hematology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 10 papers that have together received 446 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Retinoids in leukemia and cellular processes (2 papers), Lung Cancer Treatments and Mutations (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Head and Neck Cancer Studies (1 paper), Protein Degradation and Inhibitors (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (279 citations), Public Health, Environmental and Occupational Health (291 citations), Oncology (111 citations), Genetics (41 citations) and Pediatrics, Perinatology and Child Health (52 citations). C Rivas has collaborated with scholars based in Spain and Chile. Frequent co-authors include Josep‐María Ribera, Albert Oriol, Eloy del Potro, Teresa Bernal, Salut Brunet, Jesús María Hernández‐Rivas, Pilar Bastida, Evarist Feliú, Carlota Calvo and Juan Bergua. Their work appears in journals such as Haematologica, Journal of Clinical Oncology, European Journal of Cancer, International Journal of Molecular Sciences and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.